Action XOMA Royalty - XOMAO

XOMA Royalty Corporation (XOMAO) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

24,98

( - )

Prix Achat

19,35

Prix Vente

30,61

Volume échangé

3 568

24,98 Fourchette du Jour 24,99

0,00 Plage de 52 semaines 0,00

Clôture Veille

24,98

Ouverture

24,98

Dernière Transaction

24.98

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

US$ 89 140

VWAP

24,98

XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date

EMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA” or the...

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

Transaction expands Ligand’s royalty portfolio to more than 200 assets and adds seven new commercial products...

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today...

XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements

Portfolio receipts: • Achieved over $50 million of cash receipts, including $33.6 million in royalties and...

XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

EMERYVILLE, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech...

XOMA Royalty to Present at Investor Conferences in March

EMERYVILLE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech...

XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.

EMERYVILLE, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty”...

XOMA Royalty Announces CFO Transition

EMERYVILLE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq:...

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

– Takeda regains a majority of XOMA Royalty’s royalty interest in mezagitamab (TAK-079) –– XOMA Royalty will be...

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA), the biotech...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	PR
4	0	0	0	0	0	0	0	PR
12	0	0	0	0	0	0	0	PR
26	0	0	0	0	0	0	0	PR
52	0	0	0	0	0	0	0	PR
156	0	0	0	0	0	0	0	PR
260	0	0	0	0	0	0	0	PR

XOMAO - Frequently Asked Questions (FAQ)

What is the current XOMA Royalty Corporation share price?

The current share price of XOMA Royalty Corporation is US$ 24,98

What is the 1 year trading range for XOMA Royalty Corporation share price?

XOMA Royalty Corporation has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	PR
4	0	0	0	0	0	0	0	PR
12	0	0	0	0	0	0	0	PR
26	0	0	0	0	0	0	0	PR
52	0	0	0	0	0	0	0	PR
156	0	0	0	0	0	0	0	PR
260	0	0	0	0	0	0	0	PR

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	PR
4	0	0	0	0	0	0	0	PR
12	0	0	0	0	0	0	0	PR
26	0	0	0	0	0	0	0	PR
52	0	0	0	0	0	0	0	PR
156	0	0	0	0	0	0	0	PR
260	0	0	0	0	0	0	0	PR

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

XOMA Royalty Corporation (XOMAO)

XOMA Royalty Corporation (XOMAO) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

XOMAO Dernières nouvelles

XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements

XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

XOMA Royalty to Present at Investor Conferences in March

XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.

XOMA Royalty Announces CFO Transition

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements

XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

XOMA Royalty to Present at Investor Conferences in March

XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.

XOMA Royalty Announces CFO Transition

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc

XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.

XOMAO - Frequently Asked Questions (FAQ)

XOMAO Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	PR
4	0	0	0	0	0	0	0	PR
12	0	0	0	0	0	0	0	PR
26	0	0	0	0	0	0	0	PR
52	0	0	0	0	0	0	0	PR
156	0	0	0	0	0	0	0	PR
260	0	0	0	0	0	0	0	PR